WebShares of Haleon GSK and Sanofi rebounded Friday, as the companies pushed back on investor concerns about consumer litigation over the heartburn drug Zantac. WebApr 12, 2024 · Haleon , the consumer healthcare group spun out of GSK, will need to pull some surprises out of the bag in order to prompt a re-rating, says Jefferies. ... ‘But with Haleon now trading firmly at the upper end of our 13-15 times ebitda range, and Zantac out of the equation, it feels like top-line surprises will now be needed to spur any ...
GSK, Sanofi, Haleon jump after win in Zantac product …
WebAug 8, 2024 · Haleon plc (LSE: HLN) notes the recent volatility in its share price and is aware of market speculation on Haleon’s potential liability in respect of Zantac product liability litigation. Haleon is not aware of any material developments in relation to the Zantac litigation since the Haleon prospectus was issued on 1 June 2024. WebSep 20, 2024 · Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company's CEO Brian … eglon mews london
Statement re Zantac - Haleon
WebSep 20, 2024 · Haleon, spun out of GSK as an independent company in July as the world's biggest standalone consumer health business, comprises consumer health assets once owned by GSK and Pfizer. Haleon has... WebAug 12, 2024 · By Natalie Grover. LONDON (Reuters) - Shares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday after the companies said that nothing material had changed regarding U.S. litigation ... Web53 minutes ago · HALEON plc published this content on 14 April 2024 and is solely responsible for the information contained therein. Distributed by Public, ... GSK refutes California state court ruling on Zantac's cancer links: AN. 03/22: Haleon's Lisa Paley Elected as CHPA Board Chair: AQ. More news: eglon mews